UW Medicine studies suggest new multiple sclerosis patients have higher levels of pain fatigue, depression and anxiety
University of Washington medicine released research suggesting clinicians should offer non-pharmaceutical help for pain, fatigue, depression or anxiety at the time of diagnosis to patients with multiple sclerosis rather than waiting.
The study showed that patients newly-diagnosed with multiple sclerosis had higher levels of pain fatigue, depression and anxiety.
“We want to address this immediately, rather than 5 or 10 years down the road,” said Kevin Alschuler, principal investigator of this National MS Society-funded research study.
The original study in May and a companion study followed the same group of patients, mainly consisting of white females, for a year after the initial diagnosis to follow their quality of life.
“Through symptom self-management, including cognitive behavioral therapy, we help patients become empowered with coping skills, especially in the areas of fatigue and pain,” said Dawn Ehde, co-author on the quality of life study published in May.
COPYRIGHT 2022 BY KXLY. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.